- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18:10 | With late-stage trial win, Argenx preps FDA filing to push Vyvgart into broader myasthenia gravis population | ||
| 18:10 | MannKind grabs scPharmaceuticals and its heart failure infuser Furoscix in $360M deal | ||
| 18:10 | FDA does a 180, suspending use of Valneva's chikungunya vaccine | ||
| 17:10 | FDA rolls out daily updates to adverse event dashboard, plans to further 'streamline' system | ||
| 17:10 | BeOne bags $885M upfront in Royalty deal on Amgen's lung cancer drug Imdelltra | ||
| Fr | Bavarian Nordic CEO says buyout needed for vaccine specialist to reach its potential | ||
| Fr | UK pharma drug price talks break down as industry fails to lower discount rate | ||
| Fr | Novo plant acquired in Catalent buyout faces renewed FDA scrutiny with Form 483: STAT | ||
| Fr | Serena Williams gets in the Ro boat, discussing her GLP-1 use as a celebrity ambassador | ||
| Fr | Big Pharma bounces back in Q2 | ||
| Do | Ionis steps into crowded HAE market with FDA approval for Dawnzera | ||
| Do | For now, CVS declines to cover Gilead's long-acting HIV PrEP treatment Yeztugo | ||
| Do | AbbVie corporate campaign celebrates the patients, scientists behind its medicines | ||
| Do | AbbVie strengthens Rinvoq's case to treat alopecia, will send data to regulators | ||
| Do | Sarepta extends $700M debt to 2030, adds private placement amid Elevidys uncertainty | ||
| Do | Trump locks in 15% tariff rate for EU, confirming separate 'Most Favored Nation' duty for generic drugs | ||
| Do | In US manufacturing push, J&J earmarks $2B for Fujifilm in 10-year deal in North Carolina | ||
| Do | Rezolute resolves commercial question, hiring ex-Ultragenyx exec to ready for rare disease launch | ||
| Do | Nucleus RadioPharma taps former FDA head Stephen Hahn as chief executive | ||
| Mi | FDA delays 2 decisions on Regeneron's Eylea HD because of manufacturing issues | ||
| Mi | Lilly lets Kisunla shine in first DTC campaign for early Alzheimer's med | ||
| Mi | Catalent lays off 350 workers in Maryland after 'large customer' dials back orders | ||
| Mi | Novo Nordisk, under new CEO Doustdar, freezes hiring in non-critical business areas | ||
| Mi | Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter | ||
| Di | Several US pharma giants stage Q2 sales turnaround after subpar results earlier in year |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .